Biocryst Pharmaceuticals (BCRX) Revenue (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) revenue from Jun 30, 2010 to Mar 31, 2026. The TTM Biocryst Pharmaceuticals (BCRX) revenue is $886M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Biocryst Pharmaceuticals (BCRX) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +75.92% |
| 3 Years TTM | +45.14% |
| 5 Years TTM | +94.22% |
| 10 Years TTM | +34.34% |
| All Time TTM | +28.80% |
Annual Revenue change of Biocryst Pharmaceuticals (BCRX)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $156M | -82.12% |
| 2025 | $875M | +94.10% |
| 2024 | $451M | +36.00% |
| 2023 | $331M | +22.37% |
| 2022 | $271M | +72.32% |
| 2021 | $157M | +782.48% |
| 2020 | $18M | -63.53% |
| 2019 | $49M | +136.51% |
| 2018 | $21M | -18.02% |
| 2017 | $25M | -4.40% |
| 2016 | $26M | -45.40% |
| 2015 | $48M | +254.59% |
| 2014 | $14M | -21.47% |
| 2013 | $17M | -34.08% |
| 2012 | $26M | +33.86% |
| 2011 | $20M | -68.52% |
| 2010 | $62M | -16.37% |
| 2009 | $75M | N/A |
Comparison Biocryst Pharmaceuticals (BCRX) five years revenue CAGR with competitors
Biocryst Pharmaceuticals (BCRX) five years revenue CAGR is 94.22%.